Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
about
DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma.NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells.Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma.Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.ZNF148 modulates TOP2A expression and cell proliferation via ceRNA regulatory mechanism in colorectal cancer.Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.
P2860
Q33751222-0FAAE48B-9E67-4490-9E11-EF975B16A485Q34459467-3088BA0D-30C3-4D24-8F00-122D6B85A805Q35405080-C3172028-15AE-4636-B0C4-B076ADF0C8B4Q36317488-B80B8AEE-0F7B-4E81-B822-3C58E9A423BAQ37433431-0A32B865-2716-4758-83F7-A7C451939D51Q37520405-B37D6F9C-2FFD-4730-967E-8DFE5699BA7FQ37573538-919F90A3-0C2A-40B6-AD72-84EBD8C288EFQ37582692-0FA22352-B785-4DE5-AAFD-54B34A2D26AAQ38861806-A2744A2D-949F-4D46-93AD-FA10C2E81BD3Q41221347-A4397555-1B6C-4A01-9908-F477D8366B0BQ41709688-9DD391E4-F30A-43F2-85E2-31F3D7B57B88Q47812859-5148F074-86AA-4959-9783-C728D9731BB9
P2860
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Higher expression of topoisome ...... ear cell renal cell carcinoma.
@ast
Higher expression of topoisome ...... ear cell renal cell carcinoma.
@en
type
label
Higher expression of topoisome ...... ear cell renal cell carcinoma.
@ast
Higher expression of topoisome ...... ear cell renal cell carcinoma.
@en
prefLabel
Higher expression of topoisome ...... ear cell renal cell carcinoma.
@ast
Higher expression of topoisome ...... ear cell renal cell carcinoma.
@en
P2093
P2860
P1433
P1476
Higher expression of topoisome ...... ear cell renal cell carcinoma.
@en
P2093
Alexander S Parker
Bradley C Leibovich
Daniel Serie
Jeanette E Eckel-Passow
John C Cheville
Kevin J Wu
Mansi Parasramka
Tracy Hilton
P2860
P304
P356
10.1016/J.EURURO.2013.12.017
P407
P577
2013-12-25T00:00:00Z